Talent Risk

Talent Risk · Employers · Pharma & healthcare

Emergent BioSolutions

Multinational biopharmaceutical company headquartered in Gaithersburg, Maryland, USAPharma & healthcareHQ US

SignsStepping down: cuts in the last 180 days, nothing new in 90 · since 1st November 2026
Updated 21st November 202626 weeks
34
Jobs in announced cuts · 12 months
5th Aug 2026
Latest on record

Emergent BioSolutions is showing signs of job cuts.

Stepping down: cuts in the last 180 days, nothing new in 90. Latest, on 5th August: Emergent BioSolutions filed a WARN notice on 2026-08-05 for a mass layoff affecting 34 employees at its Gaithersburg, Maryland…

This record counts only cuts announced publicly or filed as a formal notice; the everyday redundancies at any large employer are rarely announced and are not here.

How to read this page
  • The label (Cutting, Signs or Quiet) comes from one published rule applied to the sources listed: the company, formal notices and named outlets. The rule
  • The figures count each announcement once. Where a figure is left out, the record says why (one report only, offered not cut, same round).
  • Summary says what is happening and what would change the label; Full record lists every report, linked.

What’s happening, and where

No announced or filed job cuts in the last 90 days. The label rests on earlier signs, under Full record.

Why, as stated Restructuring or new strategy

Next This becomes Cutting if the company, a formal notice or two major outlets confirm cuts.

The last 12 months

DecJanFebMarAprMayJunJulAugSeptOctNov5th Aug 2026: Emergent BioSolutions filed a WARN notice on 2026-08-05 for a mass layoff affecting 34 employees at its Gaithersburg, Maryland headquarters, effective 2026-10-04.34
CutsBuyouts, plans and signsHiringBigger mark = more jobs named

No cuts found this quarter. We found cuts in 1 of the three quarters before.

This label is our opinion, reached by applying one published rule to the sources listed. Emergent BioSolutions can correct the record at any time.

At a glance

LabelSigns since the week to 7th Nov
Jobs in announced cuts, 12 months34 · workforce not on our record, so no share
Latest on the record5th August 2026 · Cuts announced · 34 jobs
Where the jobs areMaryland · US
Why, as statedRestructuring or new strategy
Jobs we countAll 34 jobs reported. How we count
Normal for them?No cuts found this quarter. We found cuts in 1 of the three quarters before.
Sources, 12 months2 formal notices, each linked below
Headquarters · sectorUS · Pharma & healthcare · EBS

Identifiers Wikidata Q5370757 · LEI 549300YW6TUOX8BE5103 · ISIN US29089Q1058 · EBS on New York Stock Exchange · About these

What happened

Every event on the record, newest first. Each has its own page; open a row’s reports to see every source. How we decide

Nothing from Emergent BioSolutions, a formal notice or a named outlet about its workforce in the last 90 days.

Earlier on the record (1 event, up to a year)
  1. 5th Aug
    Emergent BioSolutions to cut 34 jobs

    Cuts announcedUSFormal notice

    Emergent BioSolutions filed a WARN notice on 2026-08-05 for a mass layoff affecting 34 employees at its Gaithersburg, Maryland headquarters, effective 2026-10-04.

    All 2 reports
    1. 5th Aug

      WARN notice (MD) Official

      Emergent BioSolutions filed a WARN notice on 2026-08-05 for a mass layoff affecting 34 employees at its Gaithersburg, Maryland headquarters, effective 2026-10-04.

    2. 5th Aug

      SEC EDGAR Official

      Emergent BioSolutions filed an 8-K disclosing costs associated with exit or disposal activities under a committed restructuring.

    Its own page, with the facts →

    34jobs cut
Background and commentary (1): in the news, never counted
  1. 2nd Nov
    Emergent BioSolutions: other

    OtherFormal notice

    Filed an 8-K with the SEC that mentions a restructuring; we have not yet read a stated job cut in it.

    The source: SEC EDGAR
    1. 2nd Nov

      SEC EDGAR Official

      Filed an 8-K with the SEC that mentions a restructuring; we have not yet read a stated job cut in it.

    No figure

Before this year: the formal record

Official documents only (US WARN notices and SEC filings) filed for Emergent BioSolutions since 2023. They are shown as filed, one row per document: a round notified at several sites appears once per site. They never change the label, which reads the last 90 days.

Formal documents by year
YearDocumentsJobs they state
20244308
20235317
Every document (9)
  1. 26th Aug 2024 WARN notice (MI) Official Emergent BioSolutions filed a WARN Act notice for a layoff affecting 68 employees at its Lansing, Michigan facility.
  2. 16th May 2024 WARN notice (MD) Official Emergent BioSolutions filed a WARN notice for plant closure affecting 86 employees at its Rockville, Maryland facility, effective 2024-08-02.
  3. 2nd May 2024 WARN notice (MD) Official Emergent BioSolutions filed a WARN notice reporting a mass layoff of 154 employees at its Gaithersburg, Maryland headquarters, effective 2024-07-01.
  4. 1st May 2024 SEC EDGAR Official Emergent BioSolutions filed an 8-K disclosing costs associated with exit or disposal activities from a committed restructuring.
  5. 8th Aug 2023 WARN notice (MD) Official Emergent BioSolutions filed a WARN notice for a mass layoff of 211 employees at its Baltimore, Maryland facility, effective 2023-10-07.
  6. 8th Aug 2023 WARN notice (MD) Official Emergent BioSolutions filed WARN notice of mass layoff affecting 20 employees at Rockville, Maryland facility, effective October 7, 2023.
  7. 8th Aug 2023 WARN notice (MA) Official Emergent BioSolutions filed a WARN notice on 2023-08-08 affecting 86 employees at its Canton, MA facility, effective 2023-10-07.
  8. 8th Aug 2023 SEC EDGAR Official Emergent BioSolutions filed an 8-K disclosing costs associated with exit or disposal activities under a committed restructuring program.
  9. 9th Jan 2023 SEC EDGAR Official Emergent BioSolutions filed an 8-K on 2023-01-09 disclosing costs associated with exit or disposal activities under a committed restructuring.

Why, and how

5th August 2026 · Cuts announced · 34 jobs

Why, as stated
Restructuring or new strategy

Only what the sources say. If no report gives a reason, we don’t suggest one.

Countries named
US

In context

How the label has changed · 26 weeks

7th NovCutting → Signs · Stepping down: cuts in the last 180 days, nothing new in 90
8th AugQuiet → Cutting · Confirmed by the company or a formal notice (such as a US WARN notice)

Share of its sector’s cuts

1%

of the 2,783 job cuts announced in 12 months by the employers we rate in pharma & healthcare.

Peers in pharma & healthcare

  1. GSK1.8%
  2. AstraZeneca0.7%
  3. Novartis0.4%
  4. Novo Nordisk0.4%
  5. Johnson & Johnson0.2%
  6. Emergent BioSolutions34 jobs

Job cuts in 12 months as a share of each employer’s workforce. Emergent BioSolutions’s workforce is not on our record, so it is shown by jobs, unranked.

Use this record RSS · JSON · Embed · Ask an AI ·
Put Emergent BioSolutions’s label on your site

Two lines show the label and the latest cut, and update themselves. No cookies. About the badge

<div data-talentrisk="emergent-biosolutions"></div>
<script async src="https://talentrisk.com/embed.js"></script>

Right of reply

Emergent BioSolutions can reply or correct this record at any time.

Correct the record →

This label is our opinion, reached by applying one published rule to the sources listed.